Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
DHCNL Diversified Healthcare Trust 625 Senior Notes Due 2046 reports narrower Q4 2025 per share loss that outperforms analyst estimates How Aeries AERT revenue breaks down and what it means Slight Gain 20260508 The structural growth drivers for James Bank BOTJ 043 20260507 VREX Varex reports strong Q1 2026 results with 40 percent EPS beat and 41 percent year over year revenue growth Power Integrations POWI Stock Builds Base Buying Pressure 20260420 DH Defin Health shares rise 202 percent despite narrow Q4 2025 EPS miss against analyst consensus estimates LegalZoomcom LZ Stock Performance Breakdown Buying Pressure 20260420 Bessent Predicts Substantial Disinflation as New Fed Chair Warsh Prepares to Take Helm US USPH Stock Analysis Falls 308 Watching 5994 20260515 Equity ELS Q1 2026 Earnings Beat Revenue NA EPS 056 Cisco Propels Wall Street to New Highs as Dow Targets 50000 Mark Sunrun RUN Faces Price Target Cuts Despite Q1 Results That Beat Market Expectations Assurant AIZ Q1 2026 Earnings EPS 595 Beats Estimates Pet Supplies Retailer Files Chapter 11 Bankruptcy Amid Industry Challenges US April Payrolls Surge Beyond Expectations Yet Red Flags Emerge Vinay Rajani of HDFC Securities Expresses Positive Outlook on LT Finance and Sandur Manganese JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India TFCI Health Ministry Tightens Pregabalin Regulations Under Schedule H1 to Curb Misuse SpaceX Filing Details Performance Milestones for Elon Musks Potential Billions BULL Q1 2026 Earnings EPS Miss Rattles Investors as Webull Faces Profitability Challenges CREG Q1 2026 Earnings Loss per Share of 003 as Company Continues Strategic Transition ALEC Q1 2026 Earnings NarrowerThanExpected Loss Surprises No Revenue Yet DOO Q1 2026 Earnings Strong EPS Beat with 55 Surprise BitFuFu FUFU Q4 2025 Earnings EPS Misses Estimates Sharply as Revenue Remains Undisclosed Gyre Therapeutics GYRE Declines 31 as Stock Tests Key Support Near 545 Reinsurance Group of America Subordinated Debentures RZC Hold Steady Near 2541 After Minimal Decline AerCap Shares Dip 199 Analyzing the Aircraft Lessors Support and Resistance Levels Lantern Pharma Inc LTRN Gains 574 as Shares Test Key Resistance Above Food Ingredients Inc ABVE Surges 9 as Buyers Test Key Resistance Source Capital Inc SOR Holds Steady Near Midpoint as Market Awaits Catalyst Jim Cramer Identifies Nvidia as Prime Beneficiary of Dells Strong Earnings Quarter Open Transaction Layer Debuts with Backing from Fireblocks Robinhood and MetaMask to Standardize PreSettlement Crypto Coordination